Patent details

EP1278543 Title: ANTIBODY BINDING ALPHA4BETA7 INTEGRIN AND ITS USE TO TREAT INFLAMMATORY BOWEL DISEASE

Basic Information

Publication number:
EP1278543
PCT Application Number:
PCT/US/2001/012234
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP019250281
PCT Publication Number:
WO/2001/078779
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ANTIBODY BINDING ALPHA4BETA7 INTEGRIN AND ITS USE TO TREAT INFLAMMATORY BOWEL DISEASE
French Title of Invention:
METHODE D'ADMINISTRATION D'UN ANTICORPS
German Title of Invention:
ANTIKÖRPER GEGEN ALPHA4BETA7 INTEGRIN UND SEIN VERWENDUNG ZUR BEHANDLUNG VON DARMERKRANKUNGEN
SPC Number:

Dates

Filing date:
13/04/2001
Grant date:
19/09/2012
EP Publication Date:
19/09/2012
PCT Publication Date:
25/10/2001
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
29/01/2003
EP B1 Publication Date:
19/09/2012
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
13/04/2013
Expiration date:
13/04/2021
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
13/04/2001
 
 

Name:
GENENTECH, INC.
Address:
1 DNA WAY, SOUTH SAN FRANCISCO CA 94080-4990, United States (US)

Name:
MILLENNIUM PHARMACEUTICALS INC.
Address:
75 Sidney Street, Cambridge, Massachusetts 02139, United States (US)

Inventor

1

Name:
BRETTMAN Lee, R.
Address:
United States (US)

2

Name:
ALLISON David, Edward
Address:
United States (US)

3

Name:
FOX Judith, A.
Address:
United States (US)

Priority

1

Priority Number:
550082
Priority Date:
14/04/2000
Priority Country:
United States (US)

2

Priority Number:
748960
Priority Date:
27/12/2000
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 39/395;
Filing date Document type Number of pages